Home Alkermes says trial results of reformulated Tecfidera show fewer side effects
 

Keywords :   


Alkermes says trial results of reformulated Tecfidera show fewer side effects

2015-02-09 15:30:42| Biotech - Topix.net

Irish drug company Alkermes says results of an early-stage trial of its reformulated version of Biogen Idec's blockbuster multiple sclerosis pill show it may have fewer side effects, and has potential to be taken once a day instead of twice. Alkermes , which has a significant research facility in Waltham, said the Phase 1 trial of 104 healthy people compared its reformulation of the active ingredient in Tecfidera, which it calls ALKS 8700, to both the original and a placebo.

Tags: show results side effects

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
26.1146 4th year birthdayLive DVD
26.11 LCD
26.11gtk
26.111/28 B-24D LIBERATOR
26.11seventeen SPILL THE FEELS standard
26.11
26.11 21 12
26.11lululemon
More »